Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer (Q81378656)
Jump to navigation
Jump to search
scientific article published on 07 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer |
scientific article published on 07 February 2005 |
Statements
Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer (English)
Beth Karlan
Michael S Gordon
Charles Taylor
Ronald B Natale
David S Mendelson
Michael F Press
David E Allison
Mark X Sliwkowski
Gracie Lieberman
Stephen M Kelsey
7 February 2005